DE69524590D1 - Zusammensetzung von 5htida und 5htid antagonisten - Google Patents

Zusammensetzung von 5htida und 5htid antagonisten

Info

Publication number
DE69524590D1
DE69524590D1 DE69524590T DE69524590T DE69524590D1 DE 69524590 D1 DE69524590 D1 DE 69524590D1 DE 69524590 T DE69524590 T DE 69524590T DE 69524590 T DE69524590 T DE 69524590T DE 69524590 D1 DE69524590 D1 DE 69524590D1
Authority
DE
Germany
Prior art keywords
5htida
composition
5htid
antagonists
5htid antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69524590T
Other languages
English (en)
Other versions
DE69524590T2 (de
Inventor
John Jones
Carol Routledge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10755726&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69524590(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of DE69524590D1 publication Critical patent/DE69524590D1/de
Publication of DE69524590T2 publication Critical patent/DE69524590T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69524590T 1994-05-25 1995-05-18 Zusammensetzung von 5htida und 5htid antagonisten Revoked DE69524590T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9410512A GB9410512D0 (en) 1994-05-25 1994-05-25 Novel treatment
PCT/EP1995/001916 WO1995031988A1 (en) 1994-05-25 1995-05-18 COMPOSITION CONTAINING 5HTIA and 5HTID ANTAGONISTS

Publications (2)

Publication Number Publication Date
DE69524590D1 true DE69524590D1 (de) 2002-01-24
DE69524590T2 DE69524590T2 (de) 2002-07-18

Family

ID=10755726

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69524590T Revoked DE69524590T2 (de) 1994-05-25 1995-05-18 Zusammensetzung von 5htida und 5htid antagonisten

Country Status (5)

Country Link
EP (1) EP0760665B1 (de)
JP (1) JPH10500674A (de)
DE (1) DE69524590T2 (de)
GB (1) GB9410512D0 (de)
WO (1) WO1995031988A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9525239D0 (en) * 1995-12-09 1996-02-07 American Home Prod Medical treatment
TR199801929T2 (xx) * 1996-03-29 1998-12-21 Pfizer Inc. Benzil(iden)-laktam t�revleri, bunlar�n 5-HT1A resept�rlerinin (ant)agonistler olarak kullan�mlar� .
UA56185C2 (uk) * 1996-09-30 2003-05-15 Пфайзер Інк. Аралкіл- та аралкіліденгетероциклічні лактами та іміди, фармацевтична композиція та спосіб лікування
SE9703374D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
DE69903992T2 (de) * 1998-04-15 2003-08-21 Pfizer Prod Inc Heterocyclische Carboxamide
ATE273970T1 (de) * 1998-04-16 2004-09-15 Pfizer Prod Inc N-acyl und n-aroyl aralkylamide
UA62015C2 (en) * 1998-12-28 2003-12-15 Pfizer Prod Inc Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)
DE10259382A1 (de) 2002-12-18 2004-07-01 Abbott Gmbh & Co. Kg 3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-4-on-Derivate, ihre Herstellung und Verwendung
MXPA06008201A (es) * 2004-01-23 2006-08-31 Amgen Inc Ligandos del receptor de vanilloide y su uso en tratamientos.
EA200601461A1 (ru) 2004-03-17 2007-02-27 Пфайзер Продактс, Инк. Новые производные бензил(иден)лактама

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
KR950702978A (ko) * 1992-08-05 1995-08-23 폴 에이. 리처 아미드 유도체(Amide derivatives)

Also Published As

Publication number Publication date
WO1995031988A1 (en) 1995-11-30
EP0760665B1 (de) 2001-12-12
EP0760665A1 (de) 1997-03-12
JPH10500674A (ja) 1998-01-20
DE69524590T2 (de) 2002-07-18
GB9410512D0 (en) 1994-07-13

Similar Documents

Publication Publication Date Title
DE69406116T2 (de) Reinigungszusammensetzung und verwendungsverfahren
DE69430662D1 (de) Zusammensetzungen von fluorkohlenwasserstoffen und kohlenwasserstoffen
DE69607321D1 (de) Reinigungsverfahren und zusammensetzung
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
DE69422791T2 (de) Sendung und Empfang von Programminformation
ATE351910T1 (de) Ob-fusionsprotein enthaltende zusammensetzungen und verfahren
DE69322395T2 (de) Feuerbeständige und hochtemperaturisolierende zusammensetzung
DE69720389D1 (de) Zementzusammensetzungen und ihre Verwendung
DE69501493D1 (de) Entfernung von Feuchtigkeit und Passivierung von Oberflächen
ATE329599T1 (de) Neue verwendung von budesonide und formoterol
DE59507427D1 (de) Mischkristalle und feste Lösungen von 1,4-Diketopyrrolopyrrolen
DE69513307D1 (de) Zusammensetzung und verwendung
DE59302386D1 (de) Verwendung von polykondensaten und neue polykondensate
DE69223984T2 (de) Zusammensetzungen von difluormethan und tetrafluorethan
DE59708905D1 (de) Injektionsformulierungen von avermectinen und milbemycinen
DE69418203T2 (de) Zementiermittel und ihre verwendung
DE69524590D1 (de) Zusammensetzung von 5htida und 5htid antagonisten
DE69816046D1 (de) Zusammensetzung auf basis von hexanitrohexaazaisowurtizitan und hexanitrohexaazaisowurtizitan enthaltende sprengstoffzusammensetzung
DE69502625D1 (de) Zusammensetzungen von nichtlinearen polystyrolen und daraus hergestellte gegenstände
DE69717677D1 (de) Koproduktion von perfluormethylperfluorvinylether und perfluorethylperfluorvinylether
BR8905444A (pt) Composicoes e aplicacao
FI943513A0 (fi) Kolekystokiniiniantagonisteina käyttökelpoisia 3-fenyyliureidoatsepin-2-oneja ja -bentsatsepin-2-oneja
DE69328467T2 (de) Polyamidzusammensetzung und Verwendung
DE69525038T2 (de) Piperidinanaloge und -konjugate von procainamid und napa
DE59501763D1 (de) Oligomerisate und Polymerisate von Aminoalkenen

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation